Some nontraditional CV risk factors associated with the inflammation-coagulation axis, such as hypersensitive C-reactive protein (hs-CRP), hyperhomocysteinemia, and increased prevalence of abnormal altered coagulation with declining renal function, have been reported to be new strong CV risk factors [3–5]. Here, CRP is linked to hyperhomocysteinemia.